Pregabid Forte 750mcg/150mg Capsule
By Pregabid Forte
Rx
10 Capsule in a Strip

Composition
Methylcobalamin(750mcg) + Pregabalin(150mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
September, 2027

liver
Based on the available information, Pregabid Forte 750mcg/150mg Capsule is considered safe to use for individuals with liver disease. Studies indicate that adjusting the dose of Pregabid Forte 750mcg/150mg Capsule may not be necessary for patients with liver conditions. However, it is crucial to consult with your doctor before using this medication to ensure it is suitable for your specific liver health needs. Your doctor will be able to provide personalized guidance and recommendations based on your individual circumstances.

kidney
Pregabid Forte 750mcg/150mg Capsule requires caution in patients with kidney disease. Dosage adjustment may be necessary. Consult your doctor.

alcohol
Avoid alcohol consumption while taking Pregabid Forte 750mcg/150mg Capsule due to potential for increased drowsiness. Consult doctor if pregnant.

driving
When taking Pregabid Forte 750mcg/150mg Capsule, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Pregabid Forte 750mcg/150mg Capsule may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Consult your doctor for a thorough evaluation of benefits and risks before using this medication.

breastfeeding
Caution is advised when breastfeeding while using Pregabid Forte 750mcg/150mg Capsule. Limited data indicates potential transfer of the drug to breastmilk, posing a risk to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | NEURO CNS |
| Action Class | - |
₹159.16
₹176.84
10% OFF
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024
